Synergy CHC Corp. Net Investment Income
Synergy CHC Corp. (SNYR) reported Net Investment Income of -$8.41 thousand for the 3-month period ending 2013-10-31, per its 10-Q filed 2013-12-06.
Discontinued › Income Statement › Other Income
us-gaap:NetInvestmentIncome · last filed 2013-12-06
- Synergy CHC Corp. net investment income for the quarter ending 2013-10-31 was -$8.41K.
- Synergy CHC Corp. net investment income for the quarter ending 2013-07-31 was -$11.59K.
- Synergy CHC Corp. net investment income for the quarter ending 2012-10-31 was -$1.84K.
- Synergy CHC Corp. net investment income for fiscal 2013 was -$23.20K.
- Synergy CHC Corp. net investment income for fiscal 2012 was -$16.20K.
| Period end | Net Investment Income 3 month | Net Investment Income 6 month | Net Investment Income 9 month | Net Investment Income 12 month | Net Investment Income 28 month | Net Investment Income 31 month | Net Investment Income 34 month |
|---|---|---|---|---|---|---|---|
| 2013-10-31 | -$8.41K 10-Q · filed 2013-12-06 | -$20.00K derived: sum of 2 quarters · filed 2013-12-06 | -$56.66K 10-Q · filed 2013-12-06 | ||||
| 2013-07-31 | -$11.59K derived: 10-K 12 month − 10-Q 9 month · filed 2013-10-28 | -$23.20K 10-K · filed 2013-10-28 | -$48.25K 10-K · filed 2013-10-28 | ||||
| 2013-04-30 | -$11.61K 10-Q · filed 2013-10-28 | -$36.66K 10-Q · filed 2013-10-28 | |||||
| 2012-10-31 | -$1.84K 10-Q · filed 2013-12-06 | ||||||
| 2012-07-31 | -$16.20K 10-K · filed 2013-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |